These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22035371)

  • 21. Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation.
    Edgar E; Woltjer R; Whitham R; Gultekin SH; Watnick S; Cupler EJ
    Neuromuscul Disord; 2010 Jun; 20(6):411-3. PubMed ID: 20462761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
    J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic systemic fibrosis: a review of the new conundrum.
    Goenka AH; Das CJ; Sharma R
    Natl Med J India; 2009; 22(6):302-6. PubMed ID: 20384019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
    Schäd SG; Heitland P; Kühn-Velten WN; Gross GE; Jonas L
    J Cutan Pathol; 2013 Nov; 40(11):935-44. PubMed ID: 24102613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nephrogenic fibrosing dermopathy].
    Brisch M; Schneider T; Requena L; Mentzel T; Kutzner H
    J Dtsch Dermatol Ges; 2003 Jun; 1(6):464-7. PubMed ID: 16295140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
    Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM
    Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K; Ezell LD; Macklin JG
    Nephrol Nurs J; 2007; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrogenic systemic fibrosis: the first Italian gadolinium-proven case.
    Bainotti S; Rota E; Bertrero M; Tamburrini O; Balducci A; Formica M
    Clin Nephrol; 2008 Dec; 70(6):514-7. PubMed ID: 19049709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Bertero M; Bainotti S; Comino A; Formica M; Giordano F; Musso L; Palazzini S; Seia Z
    Eur J Dermatol; 2009; 19(1):73-4. PubMed ID: 19171533
    [No Abstract]   [Full Text] [Related]  

  • 30. Nephrogenic systemic fibrosis: clinical picture and treatment.
    Marckmann P; Skov L
    Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.
    Swaminathan S; Bose C; Shah SV; Hall KA; Hiatt KM
    Am J Pathol; 2013 Sep; 183(3):796-807. PubMed ID: 23867799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD; Bernheisel CR
    Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of nephrogenic systemic fibrosis and calciphylaxis in a gadolinium-naïve, chronic haemodialysis patient.
    Adam MS; Jmor S; Elsayed A; Naz N
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Findings of osseous sclerotic bodies: a unique sequence of cutaneous bone formation in nephrogenic systemic fibrosis.
    Kartono F; Basile A; Roshdieh B; Schwimer C; Shitabata PK
    J Cutan Pathol; 2011 Mar; 38(3):286-9. PubMed ID: 20726931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
    Jikki PN
    J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
    [No Abstract]   [Full Text] [Related]  

  • 37. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M; Boateng F; Patel SS; Masood SF; Mahajan P; Patel N; Murray B
    Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases.
    Tsushima Y; Kanal E; Thomsen HS
    Br J Radiol; 2010 Jul; 83(991):590-5. PubMed ID: 20413447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrogenic systemic fibrosis: histology and gadolinium detection.
    Thakral C; Abraham JL
    Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alefacept therapy for nephrogenic systemic fibrosis: a case series.
    Robinson MR; Routhouska SB; Paspulati RM; Korman NJ
    J Drugs Dermatol; 2011 Aug; 10(8):922-4. PubMed ID: 21818517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.